» Articles » PMID: 30632766

Role of Matrix Metalloproteinases and Histone Deacetylase in Oxidative Stress-induced Degradation of the Endothelial Glycocalyx

Overview
Authors
Affiliations
Soon will be listed here.
Abstract

The glycocalyx is crucial for normal endothelial function. It also tethers extracellular superoxide dismutase (SOD3), which protects the endothelium against oxidative damage. Proteolytic enzymes [matrix metalloproteinases (MMPs)] are capable of disrupting endothelial cell surface proteins, such as syndecans, resulting in derangements of the endothelial glycocalyx. We sought to test the role of MMPs in oxidative stress-mediated disruption of the endothelial glycocalyx and examine the effect of pharmacological inhibition of MMPs on mitigating this detrimental effect. We also examined the role of histone deacetylase (HDAC) in the oxidative stress-mediated MMP induction and glycocalyx remodeling. Oxidative stress was experimentally induced in human adipose microvascular endothelial cells using HO and buthionine sulfoximine in the presence and absence of potent MMP and HDAC inhibitors. HO and buthionine sulfoximine resulted in a notable loss of the endothelial glycocalyx; they also increased the expression and proteolytic activity of MMP-2 and MMP-9 and subsequently increased the shedding of syndecan-1 and SOD3 from the endothelial cell surface. MMP upregulation was accompanied by a decline in mRNA and protein levels of their inhibitors, tissue inhibitors of metalloproteinase (TIMPs; TIMP-1 and TIMP-3). Furthermore, oxidative stress induced HDAC activity. Inhibition of MMPs and HDAC reversed syndecan-1 and SOD3 shedding and maintained endothelial glycocalyx integrity. HDAC inhibition increased TIMP expression and reduced MMP expression and activity in endothelial cells. Our findings shed light on MMPs and HDAC as therapeutically targetable mechanisms in oxidative stress-induced glycocalyx remodeling. NEW & NOTEWORTHY Oxidative stress, a hallmark of many diseases, damages the endothelial glycocalyx, resulting in vascular dysfunction. Studying the mechanistic link between oxidative stress and endothelial glycocalyx derangements might help discover new therapeutic targets to preserve vascular function. In this study, we investigated the involvement of matrix metalloproteinases and histone deacetylase in oxidative stress-induced endothelial glycocalyx degradation.

Citing Articles

Factors influencing glycocalyx degradation: a narrative review.

Wang J, Ma L, Fang Y, Ye T, Li H, Lan P Front Immunol. 2025; 15:1490395.

PMID: 39885987 PMC: 11779607. DOI: 10.3389/fimmu.2024.1490395.


Prolonged Cardiopulmonary Bypass Time-Induced Endothelial Dysfunction via Glypican-1 Shedding, Inflammation, and Matrix Metalloproteinase 9 in Patients Undergoing Cardiac Surgery.

Li S, Nordick K, Murrieta-Alvarez I, Kirby R, Bhattacharya R, Garcia I Biomedicines. 2025; 13(1).

PMID: 39857617 PMC: 11763025. DOI: 10.3390/biomedicines13010033.


Syndecan-1: a key player in health and disease.

Diab L, Al Kattar S, Oueini N, Hawi J, Chrabieh A, Dosh L Immunogenetics. 2024; 77(1):9.

PMID: 39688651 DOI: 10.1007/s00251-024-01366-4.


The Crucial Triad: Endothelial Glycocalyx, Oxidative Stress, and Inflammation in Cardiac Surgery-Exploring the Molecular Connections.

Curko-Cofek B, Jenko M, Taleska Stupica G, Baticic L, Krsek A, Batinac T Int J Mol Sci. 2024; 25(20).

PMID: 39456673 PMC: 11508174. DOI: 10.3390/ijms252010891.


Histone deacetylases: Regulation of vascular homeostasis via endothelial cells and vascular smooth muscle cells and the role in vascular pathogenesis.

Yang H, Guo K, Ding P, Ning J, Zhang Y, Wang Y Genes Dis. 2024; 11(6):101216.

PMID: 39281836 PMC: 11396065. DOI: 10.1016/j.gendis.2024.101216.


References
1.
Bielecka-Dabrowa A, von Haehling S, Aronow W, Ahmed M, Rysz J, Banach M . Heart failure biomarkers in patients with dilated cardiomyopathy. Int J Cardiol. 2013; 168(3):2404-10. DOI: 10.1016/j.ijcard.2013.01.157. View

2.
Sundar I, Yao H, Rahman I . Oxidative stress and chromatin remodeling in chronic obstructive pulmonary disease and smoking-related diseases. Antioxid Redox Signal. 2012; 18(15):1956-71. PMC: 3624634. DOI: 10.1089/ars.2012.4863. View

3.
Lee M, Villegas-Estrada A, Celenza G, Boggess B, Toth M, Kreitinger G . Metabolism of a highly selective gelatinase inhibitor generates active metabolite. Chem Biol Drug Des. 2007; 70(5):371-82. DOI: 10.1111/j.1747-0285.2007.00577.x. View

4.
Visse R, Nagase H . Matrix metalloproteinases and tissue inhibitors of metalloproteinases: structure, function, and biochemistry. Circ Res. 2003; 92(8):827-39. DOI: 10.1161/01.RES.0000070112.80711.3D. View

5.
Jones C, Sane D, Herrington D . Matrix metalloproteinases: a review of their structure and role in acute coronary syndrome. Cardiovasc Res. 2003; 59(4):812-23. DOI: 10.1016/s0008-6363(03)00516-9. View